Rationale for the potential use of calcitonin in osteoarthritis.

Manicourt, Daniel;Devogelaer, Jean-Pierre;Azria, M.;Silverman, S
(2005) Journal of Musculoskeletal Interactions — Vol. 5, n° 3, p. 285-293 (2005)

Files

12MANICOURT.pdf
  • Open Access
  • Adobe PDF
  • 84.9 KB

Details

Authors
  • Author
  • Devogelaer, Jean-PierreUCLouvain
    Author
  • Azria, M.
    Author
  • Silverman, S
    Author
Abstract
This review provides evidence that osteoarthritis (OA) or a major subset of OA is not only a disease of cartilage but also a disorder of subchondral bone. This review also discusses the potential efficacy of a bone and cartilage active agent, calcitonin, and discusses how calcitonin might be useful in the pharmaceutical treatment of OA.
Affiliations

Citations

Manicourt, D., Devogelaer, J.-P., Azria, M., & Silverman, S. (2005). Rationale for the potential use of calcitonin in osteoarthritis. Journal of Musculoskeletal Interactions, 5(3), 285-293. https://hdl.handle.net/2078.5/99242 (Original work published 2005)